Associations Between Birth Characteristics, Weaning Practices, and the Metabolic Syndrome in Children: A Descriptive

Teofana Otilia Bizerea-Moga1,2, Tudor Voicu Moga3,4, Ramona Stroescu1,5

  • 1Department XI of Pediatrics-1st Pediatric Discipline, Center for Research on Growth and Developmental Disorders in Children, 'Victor Babeș' University of Medicine and Pharmacy Timișoara, Eftimie Murgu Sq No. 2, 300041 Timișoara, Romania.

Metabolites
|March 26, 2025
PubMed

Insights

Children born small for gestational age (SGA) face a significantly higher risk of developing metabolic syndrome (MetS). Early life monitoring of growth and diet is crucial for preventing metabolic complications in obese children.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Obesity Research

Background:

  • Childhood obesity is a growing concern with significant health implications.
  • Metabolic syndrome (MetS) is a cluster of conditions linked to adverse cardiometabolic outcomes.
  • Early life factors like birth characteristics and feeding practices may influence MetS development in obese children.

Purpose of the Study:

  • To investigate the relationship between birth metrics and early feeding practices with MetS prevalence in obese children.
  • To identify specific risk factors contributing to MetS development in pediatric obesity.

Main Methods:

  • Retrospective observational study of 800 obese children (0-18 years) in Timișoara, Romania.
  • Patients categorized by gestational age: small for gestational age (SGA), appropriate for gestational age (AGA), and large for gestational age (LGA).
  • Analysis of birth metrics, feeding practices, BMI, and MetS components, including logistic regression and ROC analysis.

Main Results:

  • Obese children born SGA exhibited higher prevalence of Type 2 diabetes, hypercholesterolemia, insulin resistance (IR), and MetS.
  • Obese children born LGA had higher BMI, hypertriglyceridemia, arterial hypertension, and lower HDL-C.
  • MetS incidence increased with age; IR was more prevalent in older obese children. SGA birth status was a significant predictor of MetS (OR=4.49).

Conclusions:

  • Obese children born SGA have a substantially elevated risk of developing MetS.
  • MetS incidence and its components escalate with age in obese pediatric patients.
  • Close monitoring of growth patterns and early-life dietary habits is essential for mitigating metabolic complications.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.